Clicky

bioAffinity Technologies, Inc.(BIAF) News

Date Title
May 28 bioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics
May 20 BIAF Stock Rises Post Q1 Earnings Despite Revenue Decline
May 20 bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer
May 8 Independent White Paper Highlights Real-World Impact of bioAffinity Technologies’ CyPath® Lung in Diagnosing Early-Stage Lung Cancer
May 7 WallachBeth Capital Announces Closing of bioAffinity Technologies $3.25m Offering
May 7 bioAffinity Technologies Announces Closing of $3.25 Million Offering
May 7 BioAffinity Technologies announces pricing of $3.25M offering
May 6 WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.25m Offering
May 6 bioAffinity Technologies Announces Pricing of $3.25 Million Offering
May 6 The Zacks Analyst Blog Highlights Alphabet, Berkshire Hathaway, Visa and bioAffinity Technologies
May 5 Top Stock Reports for Alphabet, Berkshire Hathaway & Visa
Apr 7 BIAF Stock Surges Post Improved Earnings and Record 2024 Revenues
Mar 13 Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer
Feb 6 Zacks Initiates Coverage of bioAffinity With Neutral Recommendation
Feb 6 The Zacks Analyst Blog Highlights Amazon, Bank of America, Caterpillar, NVE and bioAffinity
Feb 5 Top Research Reports for Amazon.com, Bank of America & Caterpillar
Dec 17 Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19
Oct 9 bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test
Sep 18 Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis
Jun 12 bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests